Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17872493 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
Condition: Asthma
Interventions: Drug: Imatinib mesylate;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.